FAS mediates apoptosis, inflammation, and treatment of pathogen infection

Area of Science:

• Immunology
• Cell Biology
• Pathogen-Host Interactions

Background:

• The FAS receptor (also known as CD95 or APO-1) is a key mediator of apoptosis and inflammation.
• FAS ligand (FASL) interaction with FAS triggers diverse cellular responses, including cell death, migration, and immune modulation.
• Pathogen infections can disrupt the delicate balance of FAS/FASL signaling, influencing host responses and disease outcomes.

Purpose of the Study:

• To review the multifaceted roles of FAS-mediated apoptotic and non-apoptotic signaling in the context of pathogen infections.
• To elucidate the mechanisms by which bacterial and viral infections induce apoptosis and inflammation via the FAS pathway.
• To highlight current and emerging therapeutic strategies targeting the FAS/FASL pathway for infectious diseases and cancer.

Main Methods:

• Literature review of studies investigating FAS signaling in host-pathogen interactions.
• Analysis of molecular mechanisms underlying FAS-induced apoptosis and inflammation.
• Examination of therapeutic interventions targeting the FAS/FASL pathway.

Main Results:

• FAS signaling is implicated in both protective immunity and detrimental inflammation during infections.
• Bacterial and viral pathogens differentially modulate FAS-mediated apoptosis and inflammatory responses.
• Targeting the FAS/FASL pathway shows promise for treating infections and cancers.

Conclusions:

• The FAS/FASL pathway is a critical nexus between host defense, pathogen evasion, and disease pathogenesis.
• Understanding FAS signaling dynamics during infection is essential for developing effective immunotherapies.
• Targeted therapies offer potential for managing infectious diseases and oncological conditions by modulating FAS-mediated pathways.